DRAPER, Utah, Jan. 14, 2014 /PRNewswire/ -- Nutranomics,
Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company")
is pleased to announce that the Company's direct-to-consumer
division has been authorized to allow shareholders of NNRX stock to
purchase all products listed on the Nutranomics.com website at a
special 50% discount.
"My main goal when I created this company was to help as many
people as possible to achieve ultimate health and wellbeing.
I can't think of a better way to start off the New Year than
extending a special product discount offer to our many
shareholders," stated Dr. Tracy K.
Gibbs, CEO of Nutranomics. "Our shareholders are an
important part of the Nutranomics family, and like our many
employees, should enjoy the same significant product discounts to
help them reach their health goals in 2014."
Nutranomics has assigned the toll-free number (800) 745-0393 for
shareholders to call and order products at the exclusive 50%
discount. There is no limit on order quantity or repeat
orders. Shipping and all sales tax still apply.
Dr. Gibbs concluded, "I encourage all of our shareholders to
call and take advantage of this exclusive offer."
About Nutranomics
Nutranomics is a publicly traded company engaged in research and
development of nutritional food products. In 1997,
Nutranomics produced and branded its own product line, and began to
sell to the retail outlets and to the public. Nutranomics has
also produced formulas for hundreds of other companies.
Nutranomics' mission is to increase human health and longevity
through education and self-awareness. The Company has sales
representatives throughout North
America and Asia. Learn more about Nutranomics at
www.nutranomics.com.
For further information regarding Nutranomics, Inc., please
contact our investor relations representatives at
ir@nutranomics.com, or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements."
Statements in this press release that are not purely historical are
forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the
future. Actual results could differ from those projected in
any forward-looking statements due to numerous factors. Such
factors include, among others, the inherent uncertainties
associated with developing new products and operating as a
development stage company, our ability to raise the additional
funding we will need to continue to pursue our business and product
development plans, competition in the industry in which we operate
and market conditions. These forward-looking statements are
made as of the date of this news release, and we assume no
obligation to update the forward-looking statements, or to update
the reasons why actual results could differ from those projected in
the forward-looking statements, except as required by applicable
law, including the securities laws of the United States.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also
refer to the risk factors disclosure outlined in the reports and
other documents we file with the SEC, available at
www.sec.gov. These statements have not been evaluated by the
Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.